Ogen and Systemic lupus erythematosus - a phase IV clinical study of FDA data

Summary:

Systemic lupus erythematosus is found among people who take Ogen, especially for people who are female, 40-49 old, have been taking the drug for 5 - 10 years.

The phase IV clinical study analyzes which people take Ogen and have Systemic lupus erythematosus. It is created by eHealthMe based on reports of 2,535 people who have side effects when taking Ogen from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 30, 2022

2,535 people reported to have side effects when taking Ogen.
Among them, 6 people (0.24%) have Systemic lupus erythematosus.


What is Ogen?

Ogen has active ingredients of estropipate. eHealthMe is studying from 2,552 Ogen users for its effectiveness, alternative drugs and more.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 2,096 drugs and 1,449 conditions by eHealthMe.

Number of Ogen and Systemic lupus erythematosus reports submitted per year:

Could Ogen cause Systemic lupus erythematosus?

Time on Ogen when people have Systemic lupus erythematosus *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 100 %
  • 10+ years: 0.0 %

Gender of people who have Systemic lupus erythematosus when taking Ogen *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Systemic lupus erythematosus when taking Ogen *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 60 %
  • 50-59: 20 %
  • 60+: 20 %

Common drugs people take besides Ogen *:

  1. Premarin: 3 people, 50.00%
  2. Methotrexate: 2 people, 33.33%
  3. Alprazolam: 2 people, 33.33%
  4. Baclofen: 2 people, 33.33%
  5. Clonazepam: 2 people, 33.33%
  6. Dilantin: 2 people, 33.33%
  7. Folic Acid: 2 people, 33.33%
  8. Lortab: 2 people, 33.33%
  9. Medroxyprogesterone Acetate: 2 people, 33.33%
  10. Accolate: 2 people, 33.33%

Common side effects people have besides Systemic lupus erythematosus *:

  1. Weight Decreased: 2 people, 33.33%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 33.33%
  3. Loss Of Consciousness: 2 people, 33.33%
  4. Consciousness - Decreased: 2 people, 33.33%
  5. Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 2 people, 33.33%
  6. Thrombocytopenia (decrease of platelets in blood): 2 people, 33.33%
  7. Constipation: 2 people, 33.33%
  8. Dizziness: 1 person, 16.67%
  9. Asthma: 1 person, 16.67%
  10. Blood Creatine Phosphokinase Increased: 1 person, 16.67%

Common conditions people have *:

  1. Itching: 2 people, 33.33%
  2. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 16.67%
  3. Hypersensitivity: 1 person, 16.67%
  4. Asthma: 1 person, 16.67%
  5. Atrophic Vulvovaginitis (inflammation of the vulva): 1 person, 16.67%
  6. Breathing Difficulty: 1 person, 16.67%
  7. Cardiac Disorder: 1 person, 16.67%
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 16.67%
  9. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 16.67%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Ogen and have Systemic lupus erythematosus?

Check whether Systemic lupus erythematosus is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Systemic lupus erythematosus and when was it recovered:

Expand to all the drugs that have ingredients of estropipate:

Alternative drugs to, pros and cons of Ogen:

  • Ogen (2,552 reports)

Common Ogen side effects:

Browse all side effects of Ogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Systemic lupus erythematosus treatments and more:

COVID vaccines that are related to Systemic lupus erythematosus:

Common drugs associated with Systemic lupus erythematosus:

All the drugs that are associated with Systemic lupus erythematosus:

Common conditions associated with Systemic lupus erythematosus:

All the conditions that are associated with Systemic lupus erythematosus:

How the study uses the data?

The study uses data from the FDA. It is based on estropipate (the active ingredients of Ogen) and Ogen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: